Free Trial

Talkspace (TALK) Competitors

Talkspace logo
$2.52 +0.02 (+0.60%)
As of 09:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TALK vs. PGNY, GRAL, NHC, TDOC, VRDN, AHCO, CDNA, AGL, AVAH, and PNTG

Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Progyny (PGNY), GRAIL (GRAL), National HealthCare (NHC), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Agilon Health (AGL), Aveanna Healthcare (AVAH), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry.

Talkspace vs. Its Competitors

Progyny (NASDAQ:PGNY) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

Progyny has a net margin of 4.33% compared to Talkspace's net margin of 1.51%. Progyny's return on equity of 10.90% beat Talkspace's return on equity.

Company Net Margins Return on Equity Return on Assets
Progyny4.33% 10.90% 7.20%
Talkspace 1.51%2.54%2.15%

Progyny has higher revenue and earnings than Talkspace. Progyny is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Progyny$1.17B1.69$54.34M$0.5740.40
Talkspace$187.59M2.25$1.15M$0.02126.25

Progyny has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

Progyny presently has a consensus target price of $24.09, suggesting a potential upside of 4.61%. Talkspace has a consensus target price of $4.50, suggesting a potential upside of 78.22%. Given Talkspace's stronger consensus rating and higher probable upside, analysts clearly believe Talkspace is more favorable than Progyny.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
Talkspace
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00

94.9% of Progyny shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 9.4% of Progyny shares are held by insiders. Comparatively, 23.5% of Talkspace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Progyny had 9 more articles in the media than Talkspace. MarketBeat recorded 13 mentions for Progyny and 4 mentions for Talkspace. Talkspace's average media sentiment score of 1.71 beat Progyny's score of 0.96 indicating that Talkspace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Progyny
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Talkspace
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Progyny beats Talkspace on 10 of the 17 factors compared between the two stocks.

Get Talkspace News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TALK vs. The Competition

MetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$419.96M$1.97B$5.51B$9.31B
Dividend YieldN/AN/A4.25%4.09%
P/E Ratio126.3134.3428.1819.72
Price / Sales2.2515.34439.19110.06
Price / Cash211.2653.6035.5357.53
Price / Book3.668.638.235.67
Net Income$1.15M-$62.39M$3.23B$257.51M
7 Day Performance-8.18%-1.68%-0.61%-0.16%
1 Month Performance-11.40%11.82%6.63%9.89%
1 Year Performance15.30%4.77%27.07%15.08%

Talkspace Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TALK
Talkspace
3.7786 of 5 stars
$2.53
+0.6%
$4.50
+78.2%
+7.8%$419.96M$187.59M126.31500Positive News
High Trading Volume
PGNY
Progyny
1.0804 of 5 stars
$21.45
0.0%
$23.45
+9.3%
-23.3%$1.84B$1.17B37.63310
GRAL
GRAIL
0.6646 of 5 stars
$44.85
-4.0%
$31.50
-29.8%
+88.2%$1.68B$125.60M-0.741,360
NHC
National HealthCare
N/A$104.23
-3.9%
N/A-22.4%$1.68B$1.37B13.0612,400
TDOC
Teladoc Health
2.7205 of 5 stars
$8.06
-2.8%
$9.60
+19.1%
-21.7%$1.45B$2.57B-1.365,500
VRDN
Viridian Therapeutics
2.9952 of 5 stars
$15.89
+1.4%
$37.56
+136.3%
+5.1%$1.28B$300K-4.1350
AHCO
AdaptHealth
3.8247 of 5 stars
$9.25
-0.8%
$13.40
+44.9%
-19.3%$1.26B$3.26B16.2310,500
CDNA
CareDx
4.1217 of 5 stars
$18.45
-4.1%
$30.33
+64.4%
+3.4%$1.07B$333.79M16.04740
AGL
Agilon Health
2.4159 of 5 stars
$2.33
-4.1%
$4.79
+105.4%
-71.0%$1.01B$6.06B-3.951,076
AVAH
Aveanna Healthcare
2.1346 of 5 stars
$4.30
-7.5%
$5.20
+20.9%
+8.4%$907.19M$2.02B215.0033,500News Coverage
Analyst Forecast
High Trading Volume
PNTG
The Pennant Group
3.4827 of 5 stars
$25.85
-1.7%
$34.60
+33.8%
-13.3%$906.53M$695.24M34.017,000Analyst Forecast

Related Companies and Tools


This page (NASDAQ:TALK) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners